Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does MAGNESIUM ISOGLYCYRRHIZINATE Cause Hepatic function abnormal? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic function abnormal have been filed in association with MAGNESIUM ISOGLYCYRRHIZINATE. This represents 19.2% of all adverse event reports for MAGNESIUM ISOGLYCYRRHIZINATE.

5
Reports of Hepatic function abnormal with MAGNESIUM ISOGLYCYRRHIZINATE
19.2%
of all MAGNESIUM ISOGLYCYRRHIZINATE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Hepatic function abnormal From MAGNESIUM ISOGLYCYRRHIZINATE?

Of the 5 reports, 2 (40.0%) required hospitalization.

Is Hepatic function abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for MAGNESIUM ISOGLYCYRRHIZINATE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does MAGNESIUM ISOGLYCYRRHIZINATE Cause?

What Other Drugs Cause Hepatic function abnormal?

NIVOLUMAB (1,131) PEMBROLIZUMAB (1,079) METHOTREXATE (1,054) CABOZANTINIB S-MALATE (912) CYCLOPHOSPHAMIDE (824) BEVACIZUMAB (769) PACLITAXEL (603) LENVATINIB (528) ATORVASTATIN (520) CYCLOSPORINE (508)

Related Pages

MAGNESIUM ISOGLYCYRRHIZINATE Full Profile All Hepatic function abnormal Reports All Drugs Causing Hepatic function abnormal MAGNESIUM ISOGLYCYRRHIZINATE Demographics